Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q8MI
|
||||
Former ID |
DIB013200
|
||||
Drug Name |
Lintopride
|
||||
Synonyms |
SL-920075
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nausea [ICD10:R11] | Phase 2 | [1] | ||
Company |
Synthelabo
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C14H19ClN4O2
|
||||
Canonical SMILES |
c1(C(=O)NCC2=NCCN2CC)c(cc(c(c1)Cl)N)OC
|
||||
CAS Number |
CAS 107429-63-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 4 receptor | Target Info | Modulator | [1] | |
5-HT 3 receptor | Target Info | Modulator | [1] | ||
KEGG Pathway | Calcium signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Serotonergic synapse | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT4 type receptor mediated signaling pathway | |||||
PathWhiz Pathway | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | ||||
Reactome | Serotonin receptors | ||||
G alpha (s) signalling events | |||||
WikiPathways | Serotonin Receptor 4/6/7 and NR3C Signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | The effects of lintopride, a 5HT-4 antagonist, on oesophageal motility. Aliment Pharmacol Ther. 1995 Oct;9(5):563-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.